Literature DB >> 23787854

UK dentists' experience of iatrogenic trigeminal nerve injuries in relation to routine dental procedures: why, when and how often?

T Renton1, H Janjua, J E Gallagher, M Dalgleish, Z Yilmaz.   

Abstract

OBJECTIVES: To estimate the frequency of trigeminal nerve injuries associated with local anaesthetic administration, as experienced by UK dentists.
METHOD: A convenience sample of clinicians attending 12 study days over the UK was invited to complete an anonymised questionnaire exploring the nature of professional practice, dentists' practice demographics, experience of nerve injuries and related factors. Dental procedures related to reported trigeminal nerve injuries (TNIs) were divided into low risk, likely local anaesthetic (LA) related nerve injury, and high risk procedures, more likely to be direct nerve damage by the procedure (procedural related nerve injury). Data were analysed using Microsoft Excel and SPSS V17.
RESULTS: Overall 79% of attendees completed a questionnaire (n = 415); clinicians held an average of 19 years' clinical experience. The numbers of clinicians surveyed included general dental practitioners (n = 290; 64%) and oral surgery (OS) specialists (n = 125; 36%). The estimated incidence of TNIs for the UK GDP workforce was 3,770 TNIs per year or 0.13 TNI per dentist per year. For specialists the incidence was increased to 0.39 TNI per specialist per year. Of all injuries only half were reported, mainly to indemnity organisations. LA-related injuries were most common for GDPs and third molar surgery for OS specialists. It is estimated that TNIs will occur in 1 in 3,289 high risk procedures such as third molar surgery and 1 in 14,330 for low risk procedures, such as restorative dentistry, most likely LA-related. From 25% to 29% of these dental procedures related TNIs were permanent.
CONCLUSIONS: Nerve-related injuries in dentistry are not uncommon. Dental practitioners should be aware of the significant disability associated with iatrogenic nerve injuries and risk factors relating to LA-related trigeminal nerve injury. Clinicians should familiarise themselves with infiltration LA-techniques that may reduce these nerve injuries and with the Care Quality Commission regulations for reporting injuries to patients as a result of treatment.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23787854     DOI: 10.1038/sj.bdj.2013.583

Source DB:  PubMed          Journal:  Br Dent J        ISSN: 0007-0610            Impact factor:   1.626


  7 in total

Review 1.  Pre- and postoperative management techniques. Before and after. Part 2: the removal of third molars.

Authors:  J Mansoor
Journal:  Br Dent J       Date:  2015-03-13       Impact factor: 1.626

2.  Anatomical relationship between mental foramen, mandibular teeth and risk of nerve injury with endodontic treatment.

Authors:  Bun San Chong; Kajal Gohil; Ravikiran Pawar; Jimmy Makdissi
Journal:  Clin Oral Investig       Date:  2016-03-28       Impact factor: 3.573

Review 3.  An update on the causes, assessment and management of third division sensory trigeminal neuropathies.

Authors:  E Carter; Z Yilmaz; M Devine; T Renton
Journal:  Br Dent J       Date:  2016-06-24       Impact factor: 1.626

4.  Patient safety in primary care dentistry: where are we now?

Authors:  E Bailey; M Tickle; S Campbell
Journal:  Br Dent J       Date:  2014-10       Impact factor: 1.626

Review 5.  Inferior alveolar nerve injuries following implant placement - importance of early diagnosis and treatment: a systematic review.

Authors:  Ilana Shavit; Gintaras Juodzbalys
Journal:  J Oral Maxillofac Res       Date:  2014-12-29

6.  Prosthetically driven immediate implant placement at lower molar area; an anatomical study.

Authors:  Sabit Demircan
Journal:  Eur Oral Res       Date:  2020-01-01

7.  Risk Factor in Endodontic Treatment: Topographic Evaluation of Mandibular Posterior Teeth and Lingual Cortical Plate Using Cone Beam Computed Tomography (CT).

Authors:  Umut Aksoy; Kaan Orhan
Journal:  Med Sci Monit       Date:  2018-10-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.